Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis

The possible effects of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) on COVID-19 disease severity have generated considerable debate. We performed a single-center, retrospective analysis of hospitalized adult COVID-19 patients in Wuhan, China, who had d...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jiuyang, Huang, Chaolin, Fan, Guohui, Liu, Zhibo, Shang, Lianhan, Zhou, Fei, Wang, Yeming, Yu, Jiapei, Yang, Luning, Xie, Ke, Huang, Zhisheng, Huang, Lixue, Gu, Xiaoying, Li, Hui, Zhang, Yi, Wang, Yimin, Hayden, Frederick G., Horby, Peter W., Cao, Bin, Wang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Higher Education Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333369/
https://www.ncbi.nlm.nih.gov/pubmed/32621202
http://dx.doi.org/10.1007/s11684-020-0800-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333369/
https://www.ncbi.nlm.nih.gov/pubmed/32621202
http://dx.doi.org/10.1007/s11684-020-0800-y

Ejemplares similares